Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Ticiana Leal"'
Corrigendum: Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
Autor:
Jevin Lortie, Benjamin Rush, Katie Osterbauer, T. J. Colgan, Daiki Tamada, Sujay Garlapati, Toby C. Campbell, Anne Traynor, Ticiana Leal, Viharkumar Patel, Jeffrey J. Helgager, Kenneth Lee, Scott B. Reeder, Adam J. Kuchnia
Publikováno v:
Frontiers in Rehabilitation Sciences, Vol 3 (2022)
Externí odkaz:
https://doaj.org/article/b40b17ee5c01488e89825a27b357f9ec
Autor:
Jevin Lortie, Benjamin Rush, Katie Osterbauer, T. J. Colgan, Daiki Tamada, Sujay Garlapati, Toby C. Campbell, Anne Traynor, Ticiana Leal, Viharkumar Patel, Jeffrey J. Helgager, Kenneth Lee, Scott B. Reeder, Adam J. Kuchnia
Publikováno v:
Frontiers in Rehabilitation Sciences, Vol 3 (2022)
PurposeEstablish bedside biomarkers of myosteatosis for sarcopenia and cachexia. We compared ultrasound biomarkers against MRI-based percent fat, histology, and CT-based muscle density among healthy adults and adults undergoing treatment for lung can
Externí odkaz:
https://doaj.org/article/b2b77eccd7b44a2d85f41eee84cab729
Autor:
Andrew M. Baschnagel, Saakshi Kaushik, Arda Durmaz, Steve Goldstein, Irene M. Ong, Lindsey Abel, Paul A. Clark, Zafer Gurel, Ticiana Leal, Darya Buehler, Gopal Iyer, Jacob G. Scott, Randall J. Kimple
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Non-small cell lung cancer (NSCLC) brain metastasis cell lines and in vivo models are not widely accessible. Herein we report on a direct-from patient-derived xenograft (PDX) model system of NSCLC brain metastases with genomic annotation use
Externí odkaz:
https://doaj.org/article/cf6bf8b2cb75421fa4dbf71ed4ff419a
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/b398bb98199b42b1a49a01d088e67494
Autor:
Jennifer L Schehr, Zachery D Schultz, Jay W Warrick, David J Guckenberger, Hannah M Pezzi, Jamie M Sperger, Erika Heninger, Anwaar Saeed, Ticiana Leal, Kara Mattox, Anne M Traynor, Toby C Campbell, Scott M Berry, David J Beebe, Joshua M Lang
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159397 (2016)
Expression of programmed-death ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC) is typically evaluated through invasive biopsies; however, recent advances in the identification of circulating tumor cells (CTCs) may be a less invasive method to
Externí odkaz:
https://doaj.org/article/8f6661b01ec84d04955efc3f9136e5d9
Autor:
Elvira Cancio Assumpção, Guilherme Benjamin Pitta, Carolina Lisboa de Macedo, Gustavo Borges de Mendonça, Larissa Christyne Araújo de Albuquerque, Lívia Cavalcanti Braga de Lyra, Raquel Menezes Timbó, Ticiana Leal Leite Buarque
Publikováno v:
Jornal Vascular Brasileiro, Vol 8, Iss 2, Pp 133-138 (2009)
CONTEXTO: Dentre as maiores causas de internamento hospitalar em pacientes com diabetes melito tipos 1 e 2 estão as complicações do pé diabético, principalmente pelas sequelas, muitas vezes incapacitantes, destacando-se as amputações de membro
Externí odkaz:
https://doaj.org/article/26d1a362233d41bc9320267f8e5bd3ab
Publikováno v:
Jornal Vascular Brasileiro, Vol 7, Iss 4, Pp 333-340 (2008)
CONTEXTO: A trombose venosa profunda (TVP) é uma doença de ocorrência multidisciplinar e freqüente, incluindo as complicações relacionadas a ela, como o tromboembolismo pulmonar (TEP). Sendo a profilaxia mecânica um dos melhores (por seu baixo
Externí odkaz:
https://doaj.org/article/b6b6b86f40ac46d2a6a7d24b067883ca
Autor:
Guilherme Benjamim Brandão Pitta, Ticiana Leal e Leite, Maria do Desterro Costa e Silva, Camilla Felix Leão de Melo, Giselli de Almeida Calheiros
Publikováno v:
Jornal Vascular Brasileiro, Vol 6, Iss 4, Pp 344-351 (2007)
CONTEXTO: A trombose venosa profunda (TVP) é uma doença freqüente e grave. A profilaxia é o melhor meio para reduzir a sua incidência, diminuindo a morbimortalidade gerada por suas complicações. Na relação custo x efetividade, é melhor mant
Externí odkaz:
https://doaj.org/article/c09d0e6054e84faa91e689eb7cb19900
Autor:
Wade T. Iams, Meridith L. Balbach, Sharon Phillips, Adrian Sacher, Christine Bestvina, Vamsidhar Velcheti, Xiao Wang, Melina E. Marmarelis, Nan Sethakorn, Ticiana Leal, Paul E. Sackstein, Chul Kim, MD Andrew Robinson, Kathan Mehta, Robert Hsu, Jorge Nieva, Tejas Patil, D. Ross Camidge
Publikováno v:
Clinical Lung Cancer. 24:228-234
Autor:
Tareq Salous, Nikhil A. Shukla, Sandra K. Althouse, Susan M. Perkins, Muhammad Furqan, Ticiana Leal, Anne M. Traynor, Lawrence E. Feldman, Nasser H. Hanna, Greg A. Durm
Publikováno v:
Cancer. 129:264-271
Immunotherapy using a checkpoint inhibitor (CPI) alone or in combination with chemotherapy is the standard of care for treatment-naive patients with advanced non-small cell lung cancer (NSCLC) without driver mutations for which targeted therapies hav